← SynDRA
TOFA
SynDRA canonical compound SYN0025560 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ACACB |
| Mechanism of action | ACAT inhibitor |
All known targets
- ACACB
- ACACA
- CHAT
- Malaria ACC1
Mechanisms of action (all sources)
- ACAT inhibitor
- ACACA INHIBITOR
- ACACB INHIBITOR
- Inhibitor
Cross-references
Synonyms
- Olumacostat
- Rmi-14514
- RMI-14,514
- AC-8632
- 5-(Tetradecyloxy)-2-furoic acid
- 5-(Tetradecyloxy)-2-furancarboxylic acid
- 5-Tetradecyloxy-2-furonic acid
- RMI-14514
- UNII-BI12FRY055
- 2-Furancarboxylic acid, 5-(tetradecyloxy)-
- MDL 14514
- BRN 0539681
- 5-(tetradecyloxy)furan-2-carboxylic acid
- BI12FRY055
- CHEBI:77936
- C19H32O4
- 2-Furancarboxylic acid,5-(tetradecyloxy)-
- AC1Q5UHU
- AC1L3GNQ
- 5-(tetradecyloxy)furoic acid
- SCHEMBL543676
- 5-tetradecyloxy-2-furoic acid
- GTPL5280
- CHEMBL1562779
- TOFA, RMI 14514
- CTK5A2675
- DTXSID60203338
- Acetyl-coenzyme A carboxylase inhibitor (Parkinson's disease), Accera
- Acetyl-coenzyme A carboxylase inhibitor (Parkinson's disease), Neuera
- KD-023
- Rmi 14514
- RefChem:913224
- DTXCID60125829
- 5-tetradecoxyfuran-2-carboxylic acid
- TOFA (5-(Tetradecyloxy)-2-furoic acid)
- RMI14514;MDL14514
- CZRCFAOMWRAFIC-UHFFFAOYSA-N
- COMPOUND SUMMARY
Look up TOFA in the interactive SynDRA portal →